What is the recommended Hepatitis B (HBV) vaccination schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis B Vaccination Schedule Recommendations

The recommended Hepatitis B vaccination schedule follows a standard 3-dose regimen at 0,1, and 6 months for most individuals, with specific modifications for certain populations based on risk factors and age. 1

Standard Vaccination Schedules

Infants and Children

  • For infants born to HBsAg-negative mothers:

    • First dose: At birth (preferably before hospital discharge) or by 2 months of age
    • Second dose: 1-2 months after first dose
    • Third dose: 6 months of age 2, 1
  • For infants born to HBsAg-positive mothers:

    • First dose: Within 12 hours of birth (with HBIG)
    • Second dose: 1 month of age
    • Third dose: 6 months of age 2, 3
    • Post-vaccination testing at 9-15 months 1

Adolescents

  • Standard schedule: 0,1, and 6 months 2
  • Alternative for ages 11-15 years: 2-dose adult formulation of Recombivax HB (10 μg) at 0 and 4-6 months 1

Adults

  • Standard schedule: 0,1, and 6 months 1
  • Alternative accelerated schedule: 0,1,2, and 12 months (Twinrix) 1

Special Populations and Considerations

Hemodialysis Patients

  • 4-dose schedule at 0,1,2, and 6 months with 40 mcg/2.0 mL dose
  • Annual antibody testing recommended
  • Booster dose when anti-HBs levels decline below 10 mIU/mL 2, 1

Immunocompromised Persons

  • May require modified dosing regimens (doubled standard antigen dose or additional doses)
  • Annual anti-HBs testing and booster doses should be considered for ongoing risk 2, 1

Interrupted Schedules and Minimum Intervals

If the vaccination schedule is interrupted, the series does not need to be restarted. Follow these guidelines:

  • Minimum interval between first and second doses: 4 weeks
  • Minimum interval between second and third doses: 8 weeks
  • Minimum interval between first and third doses: 16 weeks
  • For infants, final dose not recommended before 24 weeks of age 2, 1

Post-Vaccination Testing

Post-vaccination serologic testing is recommended for:

  • Infants born to HBsAg-positive mothers
  • Healthcare personnel
  • Hemodialysis patients
  • HIV-infected persons
  • Other immunocompromised individuals
  • Sex partners of HBsAg-positive persons 2

Clinical Pearls and Pitfalls

  1. Pitfall: Restarting the series unnecessarily

    • If the schedule is interrupted, do not restart the series; simply continue where you left off 2, 1
  2. Pitfall: Inadequate dosing intervals

    • Doses given at shorter than minimum intervals should be readministered at the correct interval 2
  3. Pitfall: Missing high-risk individuals

    • Only 43.5% of high-risk patients who are screened for HBV actually receive vaccination 4
    • Patients with diabetes mellitus are less likely to be screened and vaccinated despite recommendations 4
  4. Pitfall: Incorrect administration site

    • Administer in deltoid muscle for adults and older children
    • Use anterolateral thigh for infants and neonates
    • Avoid buttock injections (lower immunogenicity) 1
  5. Important consideration: Duration of protection

    • Protection persists for at least 20 years in children who complete the series
    • Routine booster doses not recommended for immunocompetent individuals 1

The hepatitis B vaccine is highly effective, with seroprotection (anti-HBs ≥10 mIU/mL) achieved in over 95% of vaccinees 5. This high efficacy combined with proper administration according to recommended schedules is crucial for preventing both acute and chronic hepatitis B infection, which can lead to serious long-term consequences including cirrhosis and hepatocellular carcinoma 6, 7.

References

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatitis B vaccines.

Infectious disease clinics of North America, 2006

Research

Epidemiology of hepatitis B.

The Pediatric infectious disease journal, 1993

Research

Hepatitis B Vaccines.

The Journal of infectious diseases, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.